학술논문

Tumor-agnostic measurement of ctDNA levels in first line ER+, HER2-metastatic breast cancer patients as a marker for survival
Document Type
Journal
Source
CANCER RESEARCH; MAR 1 2023, 83 5, 3p. Supplement: S
Subject
Language
English
ISSN
15387445